Role of interleukin-22 in inflammatory bowel disease

doi:10.3748/wjg.v20.i48.18177

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 48

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11351)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

813

WORD

292

HTML

7553

Figures (1-2)

346

Sum=9004

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1048

Download

1299

Sum=2347

Dec 28, 2014 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (74)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Dec 28, 2014; 20(48): 18177-18188
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18177

Full Size Figure Download Figure

Figure 1 Interleukin-22 signaling pathway. IL-22 binds to a heterodimeric receptor composed of IL-10R2 and IL-22R1, activating JAK1 and TYK2, which self-phosphorylate, resulting in binding and phosphorylation of STAT3. Then, STAT3 translocates to the nucleus and induces target genes. IL: Interleukin; JAK: Janus kinase; TYK: Tyrosine protein kinase; STAT: Signal transducer and activator of transcription.

Citation: Li LJ, Gong C, Zhao MH, Feng BS. Role of interleukin-22 in inflammatory bowel disease. World J Gastroenterol 2014; 20(48): 18177-18188
URL: https://www.wjgnet.com/1007-9327/full/v20/i48/18177.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i48.18177